MCK · 8-K · 20260805PR000232

Operating Margin Drivers

MCKESSON CORP · 2026-08-05 · Importance 41 · Surprise 48 · From source text

GAAP operating income increased 27% year over year to $1.319 billion from $1.036 billion, while gross profit rose 12% to $3.685 billion. Adjusted segment operating profit increased 19% in North American Pharmaceutical to $894 million and 41% in Oncology & Multispecialty to $405 million, driven by specialty distribution, provider solutions, strategic accounts, and new product launches. Medical-Surgical Solutions adjusted operating profit declined 20% to $195 million because of product mix and one-time administrative expenses, while Prescription Technology Solutions adjusted operating profit increased 13% to $303 million.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
net_incomenegativerealized-0.3%Schedule 1: Net income attributable to noncontrolling interests for the quarter: $(418) million versus $(47) million prior year (change…